Celltrion Healthcare Co., Ltd.
http://www.celltrionhealthcare.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Celltrion Healthcare Co., Ltd.
AstraZeneca’s Evusheld Wins EU Marketing Nod For Preventing COVID-19
The European Commission is expected to make a “rapid decision” on the European Medicines Agency’s recommendation today that Evusheld should be approved.
Celltrion Celebrates Brazilian Tender Win For Infliximab
Celltrion’s Remsima infliximab biosimilar has won a Brazilian federal tender as well as several individual state bids, following earlier awards for the Korean firm’s Truxima (rituximab) and Herzuma (trastuzumab) biosimilars.
Seventeen And Counting – Bumper Crop Of New EU Filings
Orphan drugs and COVID-19 products are among the latest filings under review by the European Medicines Agency for potential pan-EU approval.
First-Of Kind BMS Drugs Among Myriad New Filings In EU
Marketing applications for 10 new drugs have been added to the latest list of products under review by the European Medicines Agency.